Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
4
×
boston top stories
life sciences
national blog main
san francisco blog main
4
×
boston
national top stories
clinical trials
indiana blog main
indiana top stories
new york blog main
san diego blog main
san francisco top stories
abbvie
allergan
alzheimer's disease
antidepressant
assurex health
astellas pharma
atlas venture
audentes therapeutics
avapritinib
avidity biosciences
bluebird bio
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brca-1
brca-2
bryan dechairo
cancer
cancer drugs
capmatinib
charles debattista
clinical trial
crispr
cymbalta
cynthia collins
deals
What
genetic
4
×
medicines
cancer
drug
experimental
treatment
abbvie
address
ago
alliance
approval
approves
biotech
biotechs
blueprint
carries
centers
certain
considering
cut
data
depression
designed
diseases
dyne
early
editas
editing
event
exits
expected
eyes
fda
gene
guesswork
guide
having
helps
humans
ipo
Language
unset
Current search:
genetic
×
biotech
×
" boston blog main "
×
" san francisco blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?